Medical Developments International Limited
MVP
Rang in aandelen
#27389
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Aandeelprijs
$0.27647164
Marktkapitalisatie
$31.15M
Verandering (1 dag)
-2.00%
Verandering (1 jaar)
-13.76%
Land
AU
Handel Medical Developments International Limited (MVP)
Categorie
Healthcare
Marktkapitalisatie van Medical Developments International Limited(MVP)
Marktkapitalisatie: $31.15M
Vanaf October 2026 heeft Medical Developments International Limited een marktkapitalisatie van $31.15M. Dit maakt Medical Developments International Limited volgens onze gegevens het 27389th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Medical Developments International Limited van 2020 tot 2026
MVP vergeleken met de top 5 populairste stocks
